Trial Profile
Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Exploratory Study of TMG-123 in Patients with Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2018
Price :
$35
*
At a glance
- Drugs TMG-123 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Teijin Pharma
- 21 Sep 2018 Status changed from active, no longer recruiting to completed.
- 14 Sep 2017 New trial record